众生药业：公司全资子公司先强药业拥有的NMN按化工原料进行生产和销售

Core Viewpoint - The company has confirmed that its wholly-owned subsidiary, Xianqiang Pharmaceutical, produces and sells NMN (β-nicotinamide mononucleotide) as a chemical raw material, in response to investor inquiries about the development of longevity drugs [1] Group 1 - The company is engaged in the production and sale of NMN [1] - NMN is identified as a chemical raw material [1]